TheraRadar
← Back
Data updated: Jul 17, 2026

RILEY CONSUMER

Specialty
Pharmaceuticals

RILEY CONSUMER is a specialty pharmaceutical company with 1 FDA-approved products.

2009
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Small Molecules

RILEY CONSUMER's Key Drugs

RILEY CONSUMER's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

RILEY CONSUMER's Recent FDA Approvals

New NDA/BLA approvals for RILEY CONSUMER over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

RILEY CONSUMER's Therapeutic Areas

Disease areas where RILEY CONSUMER has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

RILEY CONSUMER Pipeline Snapshot

Active clinical trials for RILEY CONSUMER across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling